📖 Approx. 3 minutes
In this article, an M&A advisor specializing in the healthcare industry explains from a practical perspective how mergers become a key issue in due diligence for business succession and medical M&A. We will present specific measures based on the investigation of financial, legal, labor, and clinical practices, as well as the determination of qualified vs. non-qualified mergers.
1. Industry Background of Merger Due Diligence
According to the Survey of Medical Institutions by the Ministry of Health, Labour and Welfare, the business environment for medical institutions, including due diligence, has become increasingly challenging in recent years due to a combination of factors such as medical fee revisions, rising labor costs, and capital investment burdens. In particular, interest in third-party business succession M&A is growing from the perspective of financial, legal, labor, and clinical practice investigations.
At the same time, mergers are a crucial point of discussion in medical M&A practice. By appropriately structuring the determination of qualified vs. non-qualified mergers, a succession that benefits both the transferor and the transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the workflow, patient base, and equipment status unique to due diligence, and clarify the terms of the transfer.
- Valuation: Calculate the appropriate transfer price range based on the characteristics of the clinical department. In due diligence, investigations into financial, legal, labor, and clinical practices are key to the valuation.
- Merger Design: Select the optimal scheme based on the determination of qualified vs. non-qualified mergers. Verification from tax, legal, and labor perspectives is also required.
- Sourcing & Matching: Select prospective buyers from a nationwide network that match the characteristics of the clinical department. Carefully align the desired conditions of both parties.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and clinical practice perspectives. Also verify permits, licenses, and facility standards unique to due diligence.
- Final Agreement & Closing: Execute the final agreement, including representations, warranties, and indemnification clauses. Proceed with the transfer of permits/licenses and staff notifications in parallel.
3. Specific Points to Note in Due Diligence
In medical institution M&A involving due diligence, investigations into financial, legal, labor, and clinical practices hold the key to a successful succession. There are numerous individual issues depending on the characteristics of the clinical department, such as the continuity of the patient base, employment retention of staff (physicians, nurses, co-medicals), the condition and renewal plans of equipment, and the maintenance/acquisition of facility standards.
In addition, strategic design based on market characteristics unique to due diligence—such as the breakdown of insurance-covered vs. self-pay treatment, the status of regional medical cooperation, and relationships with neighboring competing medical institutions—is crucial. Utilizing our track record in supporting due diligence successions, we assist with practical operations from an industry-specialized perspective.
4. Practical Details of Mergers
Mergers are an area that requires specialized consideration in medical M&A. Structuring based on the determination of qualified vs. non-qualified mergers is the key to success.
- Review of Relevant Laws and Practical Standards: Preparation in compliance with the Medical Care Act, tax laws, and labor regulations
- Collaboration with Experts: Working together with certified public accountants, tax accountants, attorneys, and labor attorneys
- Risk Assessment: Identifying potential risks and formulating response policies
- Consensus Building Between Parties: Designing mutually acceptable terms for both the transferor and transferee
- Proper Documentation: Clearly stating terms in the basic agreement and final contract
Frequently Asked Questions
Q. What documents are required for a consultation?
A. The process will go smoothly if you can prepare financial statements for the last three fiscal years, patient volume trends, staff composition, an equipment list, and lease agreements (if applicable) in advance. We will collect these after executing an NDA.
Q. What is the typical market price range for transfers in due diligence?
A. Due diligence is evaluated based on investigations into financial, legal, labor, and clinical practices. As a guideline, clinics without beds are valued at 0.5 to 1.5 times annual revenue, while clinics with beds or hospital-scale facilities are valued at 3 to 7 times EBITDA. We can provide details through our free simplified valuation.
Q. What are the key points to note when proceeding with a merger?
A. Prior structuring based on the determination of qualified vs. non-qualified mergers is essential. Working closely with experts to execute the process without omissions is the key to success.
Q. Will our staff or patients find out about the consultation?
A. Information is disclosed on a limited basis only after executing an NDA, and no disclosure is made to stakeholders prior to the final agreement. We strictly maintain confidentiality.
Related Columns
- Complete Guide to Hospital and Medical Corporation Business Succession | Medical M&A Practice from Successor Shortages to Success Stories
- Complete Guide to Clinic Sales and Transfers | Price Ranges, Process, and Key Points Explained by Medical M&A Experts
- How to Proceed with Medical M&A and Hospital Succession | 6 Steps from Consultation to Closing Explained with Real Examples
- Complete Guide to Tax Schemes for Medical Corporation M&A | Key Issues for Tax Accountants and CPAs
Contact M&A Medical for Consultations on Merger Due Diligence
Strict Confidentiality • Free Initial Consultation • Success Fee Basis